| A bibliometric and visual analysis of the use of ustekinumab in Crohn's disease using CiteSpace. | 2024 | Frontiers in Pharmacology |
| Comparative effectiveness and safety of ustekinumab at different intervals of maintenance phase in inflammatory bowel disease: a systematic review and meta-analysis. | 2024 | European Journal of Gastroenterology & Hepatology |
| Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: systematic review and meta-analysis. | 2024 | Pharmacological Research |
| Pharmacological therapies for the management of fistulizing Crohn's disease: a systematic review and meta-analysis. | 2023 | Journal of Crohn’s and Colitis |
| Comparative efficacy of advanced therapies for achieving endoscopic outcomes in Crohn’s disease: a systematic review and network meta-analysis. | 2023 | Clinical Gastroenterology & Hepatology |
| The use of ultrasound to detect enthesitis as a potential guide for intervention in patients with psoriasis at risk of psoriatic arthritis: a systematic review. | 2023 | International Journal of Dermatology |
| Comparative speed of early symptomatic remission with advanced therapies for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2023 | American Journal of Gastroenterology |
| Efficacy and safety of IL-12/23 and IL-23 inhibitors for Crohn's disease: systematic review and meta-analysis. | 2023 | Digestive Diseases and Sciences |
| Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis. | 2023 | BMC Gastroenterology |
| Comparative of the effectiveness and safety of biological agents, small molecule drugs, and microbiome therapies in ulcerative colitis: systematic review and network meta-analysis. | 2023 | Medicine Open |
| Use of biologics for the management of Crohn's disease: IG-IBD technical review based on the GRADE methodology. | 2023 | Digestive and Liver Disease |
| Biosimilars for the treatment of psoriasis: a systematic review of clinical trials and observational studies. | 2023 | JAMA Dermatology |
| The comparative efficacy and safety of biologics and small molecules for treating patients with ulcerative colitis in Portugal: a systematic literature review and network meta-analysis. | 2023 | European Review for Medical and Pharmacological Sciences |
| Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2023 | EClinicalMedicine |
| Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis. | 2023 | International Journal of Clinical Pharmacy |
| Systematic review and meta-analysis: association between preoperative ustekinumab and surgical complications in Crohn's disease patients. | 2023 | European Surgical Research |
| Systematic literature review of real-world evidence on dose escalation and treatment switching in ulcerative colitis. | 2023 | ClinicoEconomics and Outcomes Research |
| Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn’s disease: systematic review and network meta-analysis of randomized controlled trials. | 2023 | Inflammatory Bowel Diseases |
| The efficacy and safety of biologic drugs in the treatment of moderate-severe crohn’s disease: a systematic review. | 2023 | Pharmaceuticals |
| An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis. | 2023 | PLoS One |
| Real-world effectiveness of ustekinumab for patients with ulcerative colitis: a systematic review and meta-analysis. | 2023 | Nagoya Journal of Medical Science |
| Real-world evidence of the effectiveness and safety of ustekinumab for the treatment of Crohn’s disease: systematic review and meta-analysis of observational studies. | 2022 | Journal of Clinical Medicine |
| A systematic review with meta-analysis of comparative efficacy and safety of stekinumab and stekinumab for psoriasis treatment. | 2022 | Journal of Immunology Research |
| Biologic disease-modifying antirheumatic drugs for preventing radiographic progression in psoriatic arthritis: a systematic review and network meta-analysis. | 2022 | Pharmaceutics |
| Risk of hospitalization for serious infection after initiation of ustekinumab or other biologics in patients with psoriasis or psoriatic arthritis. | 2022 | Arthritis Care & Research |
| Is ustekinumab effective in refractory Crohn's disease of the pouch and chronic pouchitis? A systematic review. | 2022 | Digestive Diseases and Sciences |
| Adherence and persistence to biological drugs for psoriasis: systematic review with meta-analysis. | 2022 | Journal of Clinical Medicine |
| Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. | 2022 | The Lancet Gastroenterology & Hepatology |
| Ustekinumab in the treatment of patients with hidradenitis suppurativa: multicenter case series and systematic review. | 2022 | Journal of Dermatological Treatment |
| Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year. | 2022 | Journal of Dermatological Treatment |
| Effectiveness of reinduction and/or dose escalation of ustekinumab in Crohn’s disease: a systematic review and meta-analysis. | 2021 | Clinical Gastroenterology and Hepatology |
| Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review. | 2021 | Archives of Dermatological Research |
| Is ustekinumab effective in refractory Crohn’s disease of the pouch and chronic pouchitis? A systematic review. | 2021 | Digestive Diseases and Sciences |
| Biologics for pediatric psoriasis: a systematic review and meta-analysis. | 2021 | Pediatric Dermatology |
| Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. | 2021 | The Lancet Gastroenterology & Hepatology |
| Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis. | 2021 | BMJ Open Gastroenterology |
| Impact of biological agents on imaging and biomarkers of cardiovascular disease in patients with psoriasis: a systematic review and meta-analysis of randomized placebo-controlled trials. | 2021 | Journal of Investigative Dermatology |
| Postoperative outcomes after preoperative ustekinumab exposure in patients with Crohn's disease: a systematic review and meta-analysis. | 2021 | Annals of Gastroenterology |
| Dose adjustment of biologic treatments for moderate-to-severe plaque psoriasis in the real world: a systematic review. | 2021 | Dermatology and Therapy |
| Ustekinumab does not increase risk of adverse events: a meta-analysis of randomized controlled trials. | 2021 | Digestive Diseases and Sciences |
| Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn's disease: a systematic review and meta-analysis. | 2021 | Journal of Gastroenterology and Hepatology |
| Twelve-week secukinumab treatment is consistently efficacious for moderate-to-severe psoriasis regardless of prior biologic and non-biologic systemic treatment: Post hoc analysis of six randomised trials. | 2021 | Journal of the European Academy of Dermatology and Venereology |
| Efficacy of ustekinumab for active perianal fistulizing Crohn's disease: a systematic review and meta-analysis of the current literature. | 2021 | Scandinavian Journal of Gastroenterology |
| Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. | 2020 | Current Medical Research and Opinion |
| Efficacy of brodalumab for moderate to severe plaque psoriasis: a Canadian network meta-analysis. | 2020 | Journal of Cutaneous Medicine and Surgery |
| Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis. | 2020 | British Journal of Dermatology |
| First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis. | 2020 | Clinical Gastroenterology and Hepatology |
| Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review. | 2020 | Journal of the European Academy of Dermatology and Venereology |
| A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis. | 2020 | Dermatologic Therapy |
| Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis. | 2020 | RMD Open |
| Treatment algorithms for Crohn's disease. | 2020 | Digestion |
| Treatment of dactylitis and enthesitis in psoriatic arthritis with biologic agents: a systematic review and metaanalysis. | 2020 | Journal of Rheumatology |
| Effectiveness and safety of ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies. | 2019 | Expert Opinion on Biological Therapy |
| Short-term efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors brodalumab, secukinumab, ixekizumab, ustekinumab, guselkumab, tildrakizumab, and risankizumab for the treatment of moderate to severe plaque psoriasis: a systematic review and network meta-analysis of randomized controlled trials. | 2019 | Journal of Immunology Research |
| Effectiveness and safety of ustekinumab for crohn's disease; systematic review and pooled analysis of real-world evidence. | 2019 | Digestive and Liver Disease |
| Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis. | 2019 | Digestive and Liver Disease |
| Efficacy and safety of systemic treatments in psoriatic arthritis: a systematic review, meta-analysis and GRADE evaluation. | 2019 | Journal of the European Academy of Dermatology and Venereology |
| Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. | 2019 | PLoS One |
| Treatment of plaque psoriasis with IL-23p19 blockers: a systematic review and meta-analysis. | 2019 | International Immunopharmacology |
| Association of HLA-C*06:02 status with differential response to ustekinumab in patients with psoriasis: a systematic review and meta-analysis. | 2019 | JAMA Dermatology |
| Long-term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. | 2019 | Journal of the European Academy of Dermatology and Venereology |
| Time until onset of action when treating psoriatic arthritis: meta-analysis and novel approach of generating confidence intervals. | 2019 | Rheumatology International |
| Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis. | 2019 | Scandinavian Journal of Gastroenterology |
| Comparative efficacy and safety of thirteen biologic therapies for patients with moderate or severe psoriasis: a network meta-analysis. | 2019 | Journal of Pharmacological Sciences |
